Sponsor:
Masonic Cancer Center, University of Minnesota
Code:
NCT06584929
Conditions
Smoking Cessation
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Interventions
Nicoderm CQ nicotine patch
Nicorette Nicotine Lozenges
Brief summary:
Conditions
Smoking Cessation
Study ID
NCT06584929
Start date
Mar 17, 2026
Status verified date
Jul, 2026
Completion date
Aug 31, 2029
Anticipated
Primary completion date
Oct 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Enrollment
544 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: Intervention Condition
no intervention: Control Condition
no intervention: RHE - Intervention Condition
Interventions
Nicoderm CQ nicotine patch
Nicorette Nicotine Lozenges
Primary outcome measure
Central contacts
Locations
Masonic Cancer Center
Recruiting
Minneapolis, Minnesota, United States, 55455
Contacts
Sponsor
Masonic Cancer Center, University of Minnesota
Last update posted
Jul 27, 2026
Last verified
Jul, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Masonic Cancer Center, University of Minnesota on 2026-07-27.